Recursion Pharmaceuticals, Inc. (RXRX)
4.775
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 16:00
4.76
-0.02
(-0.31%)
After-Hours: 16:39
Recursion Pharmaceuticals Research and Development Expense (TTM): 433.37M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Hims & Hers Health, Inc. | -- |
| Eli Lilly & Co. | 12.56B |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Amicus Therapeutics, Inc. | 142.29M |